How much of a depressant to the BIEL share price is the fact that it trades on the Pink Sheets. If, as many say here, Whelan has been selling shares to fund the operation pending FDA approval, wouldn't sensible management have spent the money to move the company to the NASDAQ Bulletin Board?
I might be picking at old scar tissue here, but I don't intend to, I'm just asking. My broker wondered about my sanity at my buying stock on the Pink Sheets until I told him the BIEL story of my sprained ankle and what little I knew about the new FDA applications. He thought I wasn't so crazy and bought some too. I just wonder what getting the company onto an exchange would do to get BIEL into a sensible environment for brokers and investors to see the company.